Loading…
Back To Schedule
Thursday, June 17 • 12:00pm - 1:00pm
#504 OD: Right the First Time: Integrating Diagnostic Strategies into Clinical Development Plans

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Session
Level: Intermediate

Having a product approved does not guarantee uptake post approval. This session will provide recommendations to insert evidence generating diagnostic strategies earlier in clinical development and will discuss case studies on different tactics.

Learning Objectives

Identify areas of opportunity to insert diagnostic strategies to generate real-world evidence into clinical development plans; Assess existing clinical development plans for new therapeutics and integrate evidence collection to support post approval product uptake.

Chair

Earl Seltzer, MBA

Speaker

Right the First Time: Integrating Diagnostic Strategies into Clinical Development Plans
Patrick Short

Right the First Time: Integrating Diagnostic Strategies into Clinical Development Plans
Keith Hanigan

Right the First Time: Integrating Diagnostic Strategies into Clinical Development Plans
Jeffrey Shuster, PhD



Speakers
avatar for Earl Seltzer

Earl Seltzer

Senior Director, Feasibility and Site Selection, Labcorp Drug Development, United States
Earl Seltzer has over 16 years of industry experience working in the clinical investigator site space as well as at several large CROs. Earl has spent most of his time at CROs in strategic feasibility working to optimize study planning and design with data driven techniques. He has... Read More →
KH

Keith Hanigan

US Head of Precision Medicine, Blueprint Medicines , United States
PS

Patrick Short

Chief Executive Officer, Sano Genetics, United Kingdom
JS

Jeffrey Shuster

Director, Companion Diagnostics, Covance Central Laboratory Services, United States


Thursday June 17, 2021 12:00pm - 1:00pm EDT
TBD Virtual Event Horsham, PA 19044